What can we learn in drug allergy management from World Health Organization's international classifications?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/all.13335PMID 29105793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Perspectives on the International Classification of Diseases, 11th Revision, developments in allergy clinical practice in the United States.

  2017cited by this paper
• Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules

  2017cited by this paper
• Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)‐11 revision

  2017cited by this paper
• Diagnosis and management of anaphylaxis in precision medicine

  2017cited by this paper
• Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11.

  2016cited by this paper
• Updating Allergy and/or Hypersensitivity Diagnostic Procedures in the WHO ICD-11 Revision.

  2016cited by this paper
• Optimization and simplification of the Allergic and Hypersensitivity conditions classification for the ICD‐11

  2016cited by this paper
• Supporting the validation of the new allergic and hypersensitivity conditions section of the World Health Organization International Classification of Diseases-11

  2016cited by this paper
• New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11

  2016cited by this paper
• Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs

  2015cited by this paper
• Constructing a classification of hypersensitivity/allergic diseases for ICD‐11 by crowdsourcing the allergist community

  2015cited by this paper
• Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11

  2015cited by this paper
• Categorization of allergic disorders in the new World Health Organization International Classification of Diseases

  2014cited by this paper
• International Consensus on drug allergy

  2014cited by this paper
• Global classification and coding of hypersensitivity diseases – An EAACI – WAO survey, strategic paper and review

  2014cited by this paper
• Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD‐10

  2012cited by this paper
• Drug allergy: an updated practice parameter.

  2010cited by this paper
• Drug allergy: an updated practice parameter.

  2010cited by this paper
• Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.

  2006cited by this paper
• Epidemiology of life‐threatening and lethal anaphylaxis: a review

  2005cited by this paper
• Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters.

  2004cited by this paper
• Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

  2004cited by this paper
• Comprehensive clinical drug information service: first year's experience.

  1977cited by this paper
• International drug monitoring: the role of national centres. Report of a WHO meeting.

  1972cited by this paper

• Cefuroxime-induced Cardiopulmonary Arrest

  2025cites this paper
• Allergic and hypersensitivity condition in the International Patients’ Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11

  2024cites this paper
• Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11

  2024cites this paper
• Changing patterns in the epidemiology of drug allergy

  2023cites this paper
• Hypersensitivity reactions to small molecule drugs

  2022cites this paper
• Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis

  2022cites this paper
• Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement

  2022cites this paper
• Hypersensitivity Reactions to Iodinated Contrast Media

  2022cites this paper
• Editorial: Drug allergy.

  2022cites this paper
• Diagnostic approach of hypersensitivity reactions to cefazolin in a large prospective cohort.

  2021cites this paper
• Drug Hypersensitivity Quality of Life Questionnaire: validation procedures and first results of the Portuguese version

  2021cites this paper
• Dendritic cells inclusion and cell‐subset assessment improve flow‐cytometry‐based proliferation test in non‐immediate drug hypersensitivity reactions

  2021cites this paper
• Single‐dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non‐immediate reactions to beta‐lactams

  2021cites this paper
• Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children

  2021cites this paper
• β-Lactam Allergy and Cross-Reactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic

  2021cites this paper
• Preparing international classification of diseases (ICD)-11: Model of allergic and hypersensitivity conditions

  2020cites this paper
• Progress in understanding hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs

  2020cites this paper
• Reply.

  2020cites this paper
• Global implementation of the world health organization's International Classification of Diseases (ICD)‐11: The allergic and hypersensitivity conditions model

  2020cites this paper
• Advances and novel developments in drug hypersensitivity diagnosis

  2020cites this paper
• Update on perioperative hypersensitivity reactions: joint document of the Brazilian Society of Anesthesiology (SBA) and Brazilian Association of Allergy and Immunology (ASBAI) – Part I: post-crisis guidelines and treatment

  2020cites this paper
• Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

  2020cites this paper
• Drug Allergy and Anaphylaxis in Dentistry

  2020cites this paper
• Algorithm for betalactam allergy diagnosis

  2019cites this paper
• Atualização sobre reações de hipersensibilidade perioperatória: Documento conjunto da Sociedade Brasileira de Anestesiologia e Associação Brasileira de Alergia e Imunologia – Parte I: Tratamento e orientação pós-crise

  2019cites this paper
• Towards a more precise diagnosis of hypersensitivity to beta‐lactams — an EAACI position paper

  2019cites this paper
• An Update On the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions.

  2019cites this paper
• Recent developments and highlights in drug hypersensitivity

  2019cites this paper
• Food and drug allergy, and anaphylaxis in EAACI journals (2018)

  2019cites this paper
• Large Health System Databases and Drug Hypersensitivity.

  2019cites this paper
• Innovations in Health Care Delivery: Drug Allergy.

  2019cites this paper
• Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care

  2019cites this paper
• Allergies et médicaments : mécanismes de présentation de l’antigène au système immunitaire adaptatif

  2018cites this paper
• Overview of Drug Allergy: From Immunogenetic Basis to Practice.

  2018cites this paper